Open AccessUnresolved Questions in Rheumatology: Motion for Debate: The Data Support Evidence‐Based Management Recommendations for Cardiovascular Disease in Rheumatoid Arthritis
Author(s) -
Solomon Daniel H.,
Peters Mike J. L.,
Nurmohamed Michael T.,
Dixon Will
Publication year - 2013
Publication title -
arthritis & rheumatism
Language(s) - English
Resource type - Journals
eISSN - 1529-0131
pISSN - 0004-3591
DOI - 10.1002/art.37975
Subject(s) - medicine , disease , intensive care medicine , rheumatoid arthritis , glycemic , population , diabetes mellitus , rheumatology , disease management , physical therapy , environmental health , parkinson's disease , endocrinology
Cardiovascular disease (CVD) is a major source of morbidity and mortality in rheumatoid arthritis (RA). While we know much about the epidemiology and biology of this association, less is known about the treatment. This debate focuses on the management of CVD in RA: Do we know enough to set forth evidencebased recommendations? Underpinning this debate are many challenging scientific and clinical issues. First, should management focus on traditional cardiovascular risk factors or on inflammation? Second, should management of traditional cardiovascular risk factors be tailored to patients with RA, modifying treatment thresholds and targets, or are general population recommendations adequate? Third, should RA treatment be tailored to patients at risk of CVD? While these questions cannot be decided by a debate, our guest debaters have brought evidence to bear on many aspects of these topics. We are sure that you will enjoy the spirited back and forth and will come away with your own opinion of these issues.